15-77614797-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_032808.7(LINGO1):c.1110G>A(p.Pro370Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0125 in 1,610,034 control chromosomes in the GnomAD database, including 168 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0082 ( 6 hom., cov: 33)
Exomes 𝑓: 0.013 ( 162 hom. )
Consequence
LINGO1
NM_032808.7 synonymous
NM_032808.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.75
Genes affected
LINGO1 (HGNC:21205): (leucine rich repeat and Ig domain containing 1) Predicted to enable epidermal growth factor receptor binding activity. Predicted to act upstream of or within generation of neurons and protein kinase B signaling. Predicted to be located in plasma membrane. Predicted to be active in extracellular matrix and extracellular space. Implicated in autosomal recessive non-syndromic intellectual disability and glaucoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 15-77614797-C-T is Benign according to our data. Variant chr15-77614797-C-T is described in ClinVar as [Benign]. Clinvar id is 771195.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LINGO1 | NM_032808.7 | c.1110G>A | p.Pro370Pro | synonymous_variant | 2/2 | ENST00000355300.7 | NP_116197.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LINGO1 | ENST00000355300.7 | c.1110G>A | p.Pro370Pro | synonymous_variant | 2/2 | 1 | NM_032808.7 | ENSP00000347451.6 | ||
LINGO1 | ENST00000561030.5 | c.1092G>A | p.Pro364Pro | synonymous_variant | 4/4 | 1 | ENSP00000453853.1 |
Frequencies
GnomAD3 genomes AF: 0.00819 AC: 1246AN: 152226Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
1246
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00811 AC: 1950AN: 240436Hom.: 11 AF XY: 0.00814 AC XY: 1063AN XY: 130566
GnomAD3 exomes
AF:
AC:
1950
AN:
240436
Hom.:
AF XY:
AC XY:
1063
AN XY:
130566
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0130 AC: 18908AN: 1457690Hom.: 162 Cov.: 31 AF XY: 0.0126 AC XY: 9125AN XY: 724738
GnomAD4 exome
AF:
AC:
18908
AN:
1457690
Hom.:
Cov.:
31
AF XY:
AC XY:
9125
AN XY:
724738
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00818 AC: 1246AN: 152344Hom.: 6 Cov.: 33 AF XY: 0.00750 AC XY: 559AN XY: 74502
GnomAD4 genome
AF:
AC:
1246
AN:
152344
Hom.:
Cov.:
33
AF XY:
AC XY:
559
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | LINGO1: BP4, BP7, BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at